Received positive feedback on New Drug Application submission via the 505(b)(2) pathway-Company leveraging existing human pharmacokinetic data ...

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that the U.S. Food and Drug ...

The Minnesota Public Utilities Commission last month ordered Xcel to come up with electric rates for data centers that will ...

Corcept's relacorilant hits phase 3 trial success in ovarian cancer, lifting shares 90%. Click here to find out why I rate ...

Elizabeth Carlock Phillips writes in support of Trey's Law before the Texas Legislature. Her brother committed suicide after ...

"Would that law undermine employment lawyers’ ability to settle cases? My understanding is that the scholarship on this ...

Olverembatinib (HQP1351), a novel, next-generation TKI and the first third-generation BCR-ABL1 TKI, has been approved in ...

Falls Supervisors approve relocation of bus charter and tour company to Falls, data centers at Keystone Trade Center, and ...

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

Young lawyers can slam dunk their way to more success in this specialized area of the law by learning the best defenses for trade secret claims, the elements of misappropriation, what reasonable ...

Eton plans to submit a New Drug Application (NDA) to the FDA in April 2025 ... facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act ...